Stimcell Energetics Inc. financial data

Symbol
STME on OTC
Location
820 1130 Pender Street, West, Vancouver, British Columbia, Canada
State of incorporation
NV
Fiscal year end
May 31
Former names
Cell MedX Corp. (to 10/15/2024), Sports Asylum, Inc. (to 10/9/2014), Plandel Resources, Inc. (to 3/24/2014)
Latest financial report
10-Q - Q1 2025 - Apr 14, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 19.8M shares -93.3%
Entity Public Float 491K USD -72.5%
Common Stock, Value, Issued 19.8K USD -93.3%
Weighted Average Number of Shares Outstanding, Basic 19.8M shares +34.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD -100%
Research and Development Expense 44.6K USD -65.4%
General and Administrative Expense 170K USD +63.2%
Earnings Per Share, Basic -0.02 USD/shares -100%

Balance Sheet

Label TTM Value / Value Unit Change %
Other Assets, Current 10.4K USD +366%
Assets 17.1K USD -79.1%
Accounts Payable, Current 311K USD +12.2%
Accrued Liabilities, Current 8.8K USD -32.8%
Liabilities 1.09M USD +37.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax 169K USD +179%
Retained Earnings (Accumulated Deficit) -10.6M USD -4.64%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -1.07M USD -50.7%
Liabilities and Equity 17.1K USD -79.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -22.9K USD +43.2%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Common Stock, Shares Authorized 500M shares -93.3%
Common Stock, Shares, Issued 19.8M shares -93.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -22.9K USD +43.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.68K USD -91.6%
Deferred Tax Assets, Valuation Allowance 1.88M USD +0.81%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -363K USD -253%
Additional Paid in Capital 9.02M USD +4.08%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 35.1K USD -48.6%